PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Immunocompatibility Group, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK; Centre of Excellence for Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.\', \'Centre of Excellence for Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.\', \'Department of Women\'s & Children\'s Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK; Department of Rheumatology, Alder Hey Children\'s NHS Foundation Trust, Liverpool, UK.\', \'Immunocompatibility Group, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK; Centre of Excellence for Long-acting Therapeutics (CELT), Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK. Electronic address: Neill.liptrott@liverpool.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0169-409X(21)00240-410.1016/j.addr.2021.113848
?:hasPublicationType
?:journal
  • Advanced drug delivery reviews
is ?:pmid of
?:pmid
?:pmid
  • 34182016
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.09
?:rankingScore_hIndex
  • 261
is ?:relation_isRelatedTo_publication of
?:title
  • Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all